Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, aspartate 101 or leucine 137

Methods of using analogs of human basic fibroblast growth factor mutated at one or more of the positions glutamate 89, aspartate 101 or leucine 137

US Patent 6737404 · Granted May 18, 2004

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chemically modified quinoline and quinolone derivatives useful as CB-1 inverse a2017
Methods of treatment using allosteric processing inhibitors for matrix metallopr2014
Methods for designing, selecting and/or optimizing allosteric processing inhibit2014
Crystal structure of the pro form of a matrix metalloproteinase and an allosteri2014
Methods of using analogs of human basic fibroblast growth factor mutated at one 2006
Methods of using analogs of human basic fibroblast growth factor mutated at one 2006
Methods of using analogs of human basic fibroblast growth factor mutated at one 2006
High throughput method for functionally classifying proteins identified using a 2006
Microplate thermal shift assay apparatus for ligand development and multi-variab2005
Analogs of human basic fibroblast growth factor mutated at one or more of the po2004
Analogs of human basic fibroblast growth factor mutated at one or more of the po2004
Analogs of human basic fibroblast growth factor mutated at one or more of the po2004